| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Engineering vascularized skeletal muscle tissue.
|
Nat Biotechnol
|
2005
|
7.73
|
|
2
|
Soluble endoglin contributes to the pathogenesis of preeclampsia.
|
Nat Med
|
2006
|
6.21
|
|
3
|
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.
|
J Clin Invest
|
2004
|
5.59
|
|
4
|
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages.
|
J Clin Invest
|
2005
|
3.77
|
|
5
|
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms.
|
J Clin Invest
|
2002
|
3.70
|
|
6
|
Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors.
|
PLoS One
|
2008
|
3.46
|
|
7
|
An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris.
|
Proc Natl Acad Sci U S A
|
2009
|
2.59
|
|
8
|
Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis.
|
Development
|
2002
|
2.57
|
|
9
|
Development and pathology of the hyaloid, choroidal and retinal vasculature.
|
Int J Dev Biol
|
2004
|
2.56
|
|
10
|
VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.
|
J Exp Med
|
2003
|
2.52
|
|
11
|
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.
|
Am J Pathol
|
2007
|
2.27
|
|
12
|
Vascular endothelial growth factor localization in the adult.
|
Am J Pathol
|
2006
|
2.20
|
|
13
|
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.
|
J Clin Invest
|
2011
|
1.74
|
|
14
|
IGF2: epigenetic regulation and role in development and disease.
|
Cytokine Growth Factor Rev
|
2008
|
1.73
|
|
15
|
RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis.
|
FASEB J
|
2010
|
1.67
|
|
16
|
Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
|
Clin Cancer Res
|
2008
|
1.65
|
|
17
|
VEGF expression and receptor activation in the choroid during development and in the adult.
|
Invest Ophthalmol Vis Sci
|
2006
|
1.59
|
|
18
|
NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration.
|
Invest Ophthalmol Vis Sci
|
2013
|
1.58
|
|
19
|
VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma.
|
J Exp Med
|
2008
|
1.54
|
|
20
|
Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling.
|
Dev Dyn
|
2006
|
1.54
|
|
21
|
Forty-year journey of angiogenesis translational research.
|
Sci Transl Med
|
2011
|
1.51
|
|
22
|
Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
|
Cancer Res
|
2005
|
1.51
|
|
23
|
Roles for VEGF in the adult.
|
Microvasc Res
|
2007
|
1.48
|
|
24
|
TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature.
|
PLoS One
|
2009
|
1.38
|
|
25
|
Transcriptional regulation of vascular endothelial growth factor in cancer.
|
Cytokine Growth Factor Rev
|
2005
|
1.35
|
|
26
|
Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation.
|
Mol Biol Cell
|
2007
|
1.26
|
|
27
|
Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms.
|
Am J Respir Cell Mol Biol
|
2002
|
1.25
|
|
28
|
Role of shear-stress-induced VEGF expression in endothelial cell survival.
|
J Cell Sci
|
2012
|
1.21
|
|
29
|
Expression and role of VEGF in the adult retinal pigment epithelium.
|
Invest Ophthalmol Vis Sci
|
2011
|
1.21
|
|
30
|
Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism.
|
Exp Eye Res
|
2003
|
1.19
|
|
31
|
Pericyte isolation and use in endothelial/pericyte coculture models.
|
Methods Enzymol
|
2008
|
1.19
|
|
32
|
Signal transduction in vasculogenesis and developmental angiogenesis.
|
Int J Dev Biol
|
2011
|
1.17
|
|
33
|
Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling.
|
Arterioscler Thromb Vasc Biol
|
2009
|
1.14
|
|
34
|
The role of hypoxia in vascular injury and repair.
|
Annu Rev Pathol
|
2008
|
1.14
|
|
35
|
Endothelial cell-astrocyte interactions and TGF beta are required for induction of blood-neural barrier properties.
|
Brain Res Dev Brain Res
|
2004
|
1.13
|
|
36
|
Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation.
|
Stem Cells Dev
|
2004
|
1.13
|
|
37
|
Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1.
|
Mol Carcinog
|
2006
|
1.13
|
|
38
|
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California).
|
Mol Vis
|
2006
|
1.10
|
|
39
|
Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization.
|
J Cell Sci
|
2007
|
1.08
|
|
40
|
Epoxyeicosanoids promote organ and tissue regeneration.
|
Proc Natl Acad Sci U S A
|
2013
|
1.08
|
|
41
|
Wnt1 and Wnt5a affect endothelial proliferation and capillary length; Wnt2 does not.
|
Growth Factors
|
2007
|
1.03
|
|
42
|
Identification of genes involved in VEGF-mediated vascular morphogenesis using embryonic stem cell-derived cystic embryoid bodies.
|
Lab Invest
|
2004
|
1.02
|
|
43
|
Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment.
|
Cancer Res
|
2010
|
1.01
|
|
44
|
Arterial versus venous endothelial cells.
|
Cell Tissue Res
|
2008
|
1.01
|
|
45
|
Getting Tie(2)d up in angiogenesis.
|
J Clin Invest
|
2002
|
1.00
|
|
46
|
The role of RPE cell-associated VEGF₁₈₉ in choroidal endothelial cell transmigration across the RPE.
|
Invest Ophthalmol Vis Sci
|
2011
|
0.99
|
|
47
|
Vascular endothelial growth factor is important for brown adipose tissue development and maintenance.
|
FASEB J
|
2013
|
0.97
|
|
48
|
A brief history of anti-VEGF for the treatment of ocular angiogenesis.
|
Am J Pathol
|
2012
|
0.96
|
|
49
|
Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations.
|
J Mol Med (Berl)
|
2004
|
0.95
|
|
50
|
Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24.
|
Cancer Res
|
2007
|
0.92
|
|
51
|
Molecular regulation of vascular endothelial growth factor expression in the retinal pigment epithelium.
|
Mol Vis
|
2012
|
0.92
|
|
52
|
CADASIL mutations impair Notch3 glycosylation by Fringe.
|
Hum Mol Genet
|
2005
|
0.90
|
|
53
|
Role of cell and matrix-bound VEGF isoforms in lens development.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.90
|
|
54
|
The function of vascular endothelial growth factor.
|
Biofactors
|
2009
|
0.90
|
|
55
|
VEGF expression is downregulated in nitrofen-induced congenital diaphragmatic hernia.
|
J Pediatr Surg
|
2004
|
0.90
|
|
56
|
Therapeutic angiogenesis for cardiovascular disease.
|
Curr Control Trials Cardiovasc Med
|
2001
|
0.89
|
|
57
|
Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development.
|
Dev Biol
|
2011
|
0.89
|
|
58
|
The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.
|
Invest Ophthalmol Vis Sci
|
2012
|
0.86
|
|
59
|
The role of shear-induced transforming growth factor-β signaling in the endothelium.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.86
|
|
60
|
ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter.
|
Biochem Biophys Res Commun
|
2005
|
0.86
|
|
61
|
Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo.
|
Blood
|
2012
|
0.84
|
|
62
|
Expression and role of VEGF--a in the ciliary body.
|
Invest Ophthalmol Vis Sci
|
2012
|
0.83
|
|
63
|
Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity.
|
FASEB J
|
2011
|
0.81
|
|
64
|
From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy.
|
Curr Diab Rep
|
2015
|
0.80
|
|
65
|
Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration.
|
Pathology
|
2014
|
0.79
|
|
66
|
Culture of large vessel endothelial cells on floating collagen gels promotes a phenotype characteristic of endothelium in vivo.
|
Differentiation
|
2004
|
0.78
|
|
67
|
Tales of the cryptic: unveiling more angiogenesis inhibitors.
|
Trends Mol Med
|
2002
|
0.76
|
|
68
|
All vessels are not created equal.
|
Am J Pathol
|
2013
|
0.76
|
|
69
|
Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.
|
Invest Ophthalmol Vis Sci
|
2009
|
0.75
|
|
70
|
Editorial.
|
Microvasc Res
|
2010
|
0.75
|
|
71
|
Judah Folkman's contribution to the inhibition of angiogenesis.
|
Lymphat Res Biol
|
2008
|
0.75
|